Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden

NCT04840186 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT04840186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04840186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Suspended
Start date
March 23, 2021
Completion date
March 31, 2026
Enrollment
62 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, liver metastases